Overview

A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting

Status:
Completed

Trial end date:
2018-04-27

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy of intravenous brivaracetam (BRV) compared to intravenous lorazepam (LZP) in subjects with epilepsy undergoing Epilepsy Monitoring Unit (EMU) evaluation who experience seizures that require prompt treatment.

Phase:

Phase 2

Details

Lead Sponsor:

UCB Biopharma S.P.R.L.

Treatments:

Brivaracetam
Lorazepam